The notices it replaced
- Reissues: PAR-22-090 Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
- 2 steps back: PAR-19-149 Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
- 3 steps back: PA-18-286 Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
- 4 steps back: PA-16-040 Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21)
- 5 steps back: PA-12-284 Exploratory/Developmental Bioengineering Research Grants (EBRG) [R21]
- 6 steps back: PA-10-010 Exploratory/Developmental Bioengineering Research Grants (EBRG) [R21]
- 7 steps back: PA-06-418 Exploratory/Developmental Bioengineering Research Grants(EBRG) [R21]
- 8 steps back: PA-03-058
Who won it before
388 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $86,793,242 in first-year total cost, median $213,152.
Most frequent study sections
- Bioengineering, Technology and Surgical Sciences Study Section[BTSS]26
- Biomedical Imaging Technology A Study Section[BMIT-A]25
- Nanotechnology Study Section[NANO]17
- Biomaterials and Biointerfaces Study Section[BMBI]15
- Biomedical Imaging Technology B Study Section[BMIT-B]15
Most frequent institutions
- UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN15
- STANFORD UNIVERSITY12
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH10
- DUKE UNIVERSITY9
- CASE WESTERN RESERVE UNIVERSITY8
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | A Pathomimetic Gingiva-on-a-Chip for Assessing Microbiota-Directed Anti-Inflammatory Therapeutics1R21DE035249-01 · under PAR-22-090 | STACY, APOLLO | CLEVELAND CLINIC LERNER COM-CWRU, OH | $442,750 | ODCS |
| 2025 | Development of an Integrated Dental Plaque Bioanalytical Platform for Point-of-Care Diagnostics of Oral Diseases1R21DE034919-01 · under PAR-22-090 | KOLEY, DIPANKAR | OREGON STATE UNIVERSITY, OR | $422,665 | ZRG1 |
| 2025 | Underlying vasculature and perivasculature direct fluid flow in and around tumors1R21CA297765-01A1 · under PAR-22-090 | MUNSON, JENNIFER M | VIRGINIA POLYTECHNIC INST AND ST UNIV, VA | $411,583 | CNBT |
| 2025 | 3D High Density Collagen I Improves Modeling of Metastatic Pancreatic Cancer1R21CA306070-01 · under PAR-22-090 | FRALEY, STEPHANIE IRENEWHITE, REBEKAH | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $410,115 | ZRG1 |
| 2025 | Biomimetic Nitric Oxide and Hydroxyapatite Duo for Advanced Direct Pulp Capping1R21DE034497-01A1 · under PAR-22-090 | CHEON, KYOUNGA | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $408,375 | ODCS |
| 2025 | Dissecting the structure-function relationship of the Wnt destruction complex condensate1R21CA301306-01 · under PAR-22-090 | WILSON, MAXWELL ZANE | UNIVERSITY OF CALIFORNIA SANTA BARBARA, CA | $402,400 | BCO |
| 2025 | Enhanced treatment of breast cancer via biodegradable polymer nanoparticles1R21CA297703-01A1 · under PAR-22-090 | CORMODE, DAVID PETER | UNIVERSITY OF PENNSYLVANIA, PA | $391,826 | IPCA |
| 2025 | Microfluidic immunotherapy screening on a core needle biopsy1R21CA297495-01A1 · under PAR-22-090 | LEE, STEVE SEUNG-YOUNG | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $386,279 | ZRG1 |
| 2025 | Heating Magnetic Nanoparticles using Low Frequency Ferromagnetic Resonance1R21CA297246-01 · under PAR-22-090 | WEAVER, JOHN B | DARTMOUTH-HITCHCOCK CLINIC, NH | $226,704 | ITD |
| 2025 | Tumor-site activated T cell redirecting autoantibodies1R21CA301137-01 · under PAR-22-090 | TSOURKAS, ANDREW | UNIVERSITY OF PENNSYLVANIA, PA | $216,682 | TIO |
| 2025 | Synthetic Mechano-Transduction For Improved Cell Therapies In Immuno-Oncology1R21CA294038-01A1 · under PAR-22-090 | BERRO, JULIENSU, XIAOLEI | YALE UNIVERSITY, CT | $195,766 | CIC |
| 2025 | Halting Breast Cancer Metastasis by Blocking Cancer-MSC Engulfment1R21CA293424-01A1 · under PAR-22-090 | CHEN, YU-CHIH | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $180,632 | TEHM |
| 2025 | Advanced 3D auxetic biodegradable implant for large volume breast reconstruction1R21CA290907-01A1 · under PAR-22-090 | PARK, JEONG HUN | GEORGIA INSTITUTE OF TECHNOLOGY, GA | $155,028 | BTSS |
| 2024 | Characterization of drug mechanisms of lethality in vivo1R21CA294000-01 · under PAR-22-090 | LEE, MICHAEL JUNGHO | UNIV OF MASSACHUSETTS MED SCH WORCESTER, MA | $430,684 | MCTA |
| 2024 | On-Demand Modulation of Extracellular Matrix Mechanics for Studying RhoA Activation in Primary and Metastatic Colorectal Cancer1R21CA283686-01A1 · under PAR-22-090 | DEFOREST, COLE AGRADY, WILLIAM MALLORY | UNIVERSITY OF WASHINGTON, WA | $428,361 | ZRG1 |
| 2024 | isomiRGate: a comprehensive gateway for studying the canonical and modified microRNAomes in Cancer1R21CA287180-01A1 · under PAR-22-090 | NIGITA, GIOVANNI | OHIO STATE UNIVERSITY, OH | $390,290 | CG |
| 2024 | Local Administration of Particle-Anchored Cytokines as a Safe and Effective Cancer Immunotherapy1R21CA287324-01A1 · under PAR-22-090 | TONG, RONG | VIRGINIA POLYTECHNIC INST AND ST UNIV, VA | $379,981 | DBTD |
| 2024 | Engineered exosome mimetics as targeted biological nanomedicines for pancreatic cancer1R21CA283420-01A1 · under PAR-22-090 | MOSES, MARSHA A | BOSTON CHILDREN'S HOSPITAL, MA | $248,243 | ATA |
| 2024 | Development of a Synovium-on-a-Chip Microphysiological System to Interrogate Pathobiology and Enhance Precision Medicine in Rheumatoid Arthritis1R21AR083247-01A1 · under PAR-22-090 | CHEN, WEIQIANGWAMPLER MUSKARDIN, THERESA | NEW YORK UNIVERSITY, NY | $235,690 | ZRG1 |
| 2024 | ATP-responsive Nanoparticles for Reversal of Immune Evasion in Breast Cancer1R21CA286977-01 · under PAR-22-090 | MING, XINTIAN, SHAOMIN | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $230,525 | ZRG1 |
| 2024 | Designing inducible chemotactic beacons for enhanced trafficking of CAR T cells to solid tumors1R21CA280726-01A1 · under PAR-22-090 | SARKAR, SUROJIT | SEATTLE CHILDREN'S HOSPITAL, WA | $230,127 | CIC |
| 2024 | Improving Accuracy of Next-Generation Microscopy for Early Stage Metastatic Melanoma Detection1R21CA280272-01A1 · under PAR-22-090 | WARREN, WARREN S | DUKE UNIVERSITY, NC | $217,875 | CMT |
| 2024 | A Topical Plasmid-based Approach to Cervical Cancer Screening1R21CA283638-01A1 · under PAR-22-090 | WARRAM, JASON MORGAN | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $205,516 | MCDC |
| 2024 | Improving safety and access to immune effector cell therapy with artificial intelligence technology1R21CA286980-01 · under PAR-22-090 | BACHANOVA, VERONIKA SPAKHOMOV, SERGUEI VS | UNIVERSITY OF MINNESOTA, MN | $176,806 | ZRG1 |
| 2023 | Unbiased electrothermal flow-enhanced identification of antigen-specific T cells in lung cancer1R21CA283852-01 · under PAR-22-090 | LILLEHOJ, PETER BREUBEN, ALEXANDRE | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $412,768 | CIC |
| 2023 | A Scalable Continuous Production Platform for Large-Scale Manufacturing of Therapeutic Exosomes1R21CA277663-01A1 · under PAR-22-090 | WANG, YICHUN | UNIVERSITY OF NOTRE DAME, IN | $402,404 | ZRG1 |
| 2023 | Programmable peptide-guided protein degradation1R21CA278468-01A1 · under PAR-22-090 | CHATTERJEE, PRANAM | DUKE UNIVERSITY, NC | $387,702 | MSFA |
| 2023 | Role of FAP-positive cells in immune response to irradiated glioblastoma1R21CA280787-01 · under PAR-22-090 | VANPOUILLE-BOX, CLAIRE ISABELLE | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $237,724 | RTB |
| 2023 | Understanding the in vivo impact of immunotherapies in splenic lymphoma by intravital three-photon microscopy1R21CA277513-01 · under PAR-22-090 | XU, CHRIS | CORNELL UNIVERSITY, NY | $233,883 | ZRG1 |
| 2023 | Accelerating genomic analysis for time critical clinical applications1R21CA271098-01A1 · under PAR-22-090 | MARTH, GABOR TQIAO, YI | UNIVERSITY OF UTAH, UT | $215,635 | BDMA |
| 2023 | Single viewpoint panoramic imaging technology for colonoscopy1R21CA277667-01 · under PAR-22-090 | LIANG, RONGGUANG | UNIVERSITY OF ARIZONA, AZ | $209,228 | ZRG1 |
| 2023 | Particle-Assisted Control over Macrophage-Neutrophil interactions (Pac-Man)1R21AR083080-01 · under PAR-22-090 | SPILLER, KARA LORRAINE | DREXEL UNIVERSITY, PA | $199,980 | ZRG1 |
| 2023 | Noninvasive monitoring of therapeutic response to immune checkpoint inhibitors using circulating exosomes in non-small cell lung cancer1R21CA283881-01 · under PAR-22-090 | DAUNERT, SYLVIA | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $179,403 | MCDC |
| 2022 | An inorganic polyphosphate-impregnated synthetic periosteum drives allograft osteointegration1R21AR080914-01 · under PAR-19-149 | MCCARTHY, JASON R.SCHOENECKER, JONATHAN | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $245,974 | MTE |
| 2022 | Advanced planar image reconstruction for targeted alpha therapy1R21CA263876-01A1 · under PAR-19-149 | SCHMIDTLEIN, CHARLES ROSS | SLOAN-KETTERING INST CAN RESEARCH, NY | $241,840 | RTB |
| 2022 | A liquid cathode for medical imaging X-ray sources1R21CA260019-01A1 · under PAR-19-149 | SCHWOEBEL, PAUL R | SRI INTERNATIONAL, CA | $234,019 | ITD |
| 2022 | Early tumorigenesis in vivo imaging, scRNA-seq to functional assays1R21CA267849-01 · under PAR-19-149 | FRASER, SCOTT EGOLDKORN, AMIRKITANO, MASAHIROSMITH, ANDREW DAVID | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $231,413 | CMT |
| 2022 | Biodegradable liquid metal nanoagents for photoacoustic image-guided photodynamic therapy1R21CA263694-01A1 · under PAR-19-149 | MALLIDI, SRIVALLEESHA | TUFTS UNIVERSITY MEDFORD, MA | $225,945 | RTB |
| 2022 | Sorting and characterization of cancer cells based on metabolic phenotype1R21CA271715-01 · under PAR-19-149 | REINHART-KING, CYNTHIA A. | VANDERBILT UNIVERSITY, TN | $222,296 | ZRG1 |
| 2022 | Bioinspired nanovectors for CRISPR/Cas9-mediated CAR T cell manufacturing1R21CA260247-01A1 · under PAR-19-149 | KWONG, GABRIEL A | GEORGIA INSTITUTE OF TECHNOLOGY, GA | $221,876 | GDD |
| 2022 | Targeted Anchoring Ecto-enzyme on Cancer Cell Surface to Enhance Antibody Therapy in Breast Cancer1R21CA267853-01 · under PAR-19-149 | MING, XIN | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $217,388 | ZRG1 |
| 2022 | Stimuli-responsive Delivery of Ectonucleotidase Inhibitors to Reprogram Immunometabolism in Head and Neck Cancer1R21CA263759-01A1 · under PAR-19-149 | MING, XIN | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $217,388 | DMP |
| 2022 | An organ-on-a-chip model system to study prostate cancer metastasis into vascularized bone1R21CA263860-01A1 · under PAR-19-149 | BERTASSONI, LUIZ EDUARDOMORAN, AMY E | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $215,985 | MTE |
| 2022 | Knifeless Limb Lengthening: Critical Advancement of an Innovative Therapy1R21AR080361-01 · under PAR-19-149 | HALANSKI, MATTHEW AHALL, TIMOTHY L | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $214,866 | IGIS |
| 2022 | Nanoparticles for In Vivo Labeling of T Cells During Cancer Immunotherapy1R21CA263653-01A1 · under PAR-19-149 | RINALDI-RAMOS, CARLOS M | UNIVERSITY OF FLORIDA, FL | $205,144 | CII |
| 2022 | Integrating in vivo and in silico models of prostate cancer-bone interactions to overcome anti-tumor therapy resistance1R21CA267312-01A1 · under PAR-19-149 | CASARIN, STEFANODONDOSSOLA, ELEONORA | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $203,567 | RTB |
| 2022 | Peptide conjugated liposomes activate anti-tumor immunity1R56CA260972-01A1 · under PAR-19-149 | AUGUSTE, DEBRA | NORTHEASTERN UNIVERSITY, MA | $200,000 | GDD |
| 2022 | Colocalization of gene expression and microscale tissue strains in live tendon explants using barcoded biosensors1R21AR079095-01A1 · under PAR-19-149 | SZCZESNY, SPENCERWONG, PAK KIN | PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA | $199,139 | CMT |
| 2022 | Radiosensitization of thyroid cancer by cancer cell specific reduction of gold ions1R21CA259839-01A1 · under PAR-19-149 | LAI, STEPHEN YSOKOLOV, KONSTANTIN V | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $189,338 | RTB |
| 2022 | Novel Mechano-Acoustic Enhancement of Immunotherapy1R21CA256708-01A1 · under PAR-19-149 | EL KAFFAS, AHMED | STANFORD UNIVERSITY, CA | $184,740 | IGIS |
| 2022 | A Bioengineered Model of Tumor Vessel Interactions in Pancreatic Cancer1R21CA252162-01A1 · under PAR-19-149 | LEE, ESAK | CORNELL UNIVERSITY, NY | $183,164 | TPM |
| 2022 | A Cas13d-based screening approach to engineer exhaustion-resistant CAR T cells1R21CA270609-01 · under PAR-19-149 | QI, LEI STANLEY | STANFORD UNIVERSITY, CA | $182,863 | CII |
| 2022 | Characterizing Motor Unit Mechanics and Muscle Contractile Properties In Vivo1R21AR079650-01A1 · under PAR-19-149 | SON, JONGSANG | NEW JERSEY INSTITUTE OF TECHNOLOGY, NJ | $164,142 | MRS |
| 2021 | Development of nanoparticulate solution for cancer treatment by breakup of tumor extracellular hydroxyapatite: a new paradigm1R21CA252629-01A1 · under PAR-19-149 | TANTAWY, MOHAMMED NOOR | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $472,960 | DMP |
| 2021 | High-efficiency microfluidic cell fusion for dendritic cell/tumor cell vaccine production1R21CA259840-01 · under PAR-19-149 | AVIGAN, DAVID E.VOLDMAN, JOEL | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | $428,524 | ISD |
| 2021 | An information-theoretic approach to HP signal acquisition in brain1R21CA249373-01A1 · under PAR-19-149 | BANKSON, JAMES AFUENTES, DAVID | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $416,543 | EITA |
| 2021 | Development of a novel imaging modality for adoptive cell therapy1R21CA262736-01A1 · under PAR-19-149 | EXNER, AGATA AWALD, DAVID | CASE WESTERN RESERVE UNIVERSITY, OH | $413,974 | ZRG1 |
| 2021 | Development of a Theranostic Nanomedicine Construct for Ovarian Cancer1R21CA249819-01A1 · under PAR-19-149 | GARRISON, JERED C | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $390,858 | IPCA |
| 2021 | An ex vivo system to model the inflammatory microenvironment of human disc herniation1R21AR078547-01A1 · under PAR-19-149 | LI, XUDONG J.POMPANO, REBECCA R | UNIVERSITY OF VIRGINIA, VA | $388,230 | SBSR |
| 2021 | High-Resolution Dynamic Imaging of Ovarian Cancer Metastasis Post Chemotherapy1R21CA256615-01 · under PAR-19-149 | IWANICKI, MARCINWANG, SHANG | THE TRUSTEES OF THE STEVENS INSTITUTE OF TECHNOLOGY, NJ | $235,103 | IGIS |
| 2021 | Developing mathematical model driven optimized recurrent glioblastoma therapies1R21CA263911-01 · under PAR-19-149 | ENDERLING, HEIKOYU, HSIANG-HSUAN MICHAEL | H. LEE MOFFITT CANCER CTR & RES INST, FL | $230,992 | MABS |
| 2021 | Microfluidic platforms to generate 'off-the-shelf' fratricide-resistant CAR T cells for T-cell malignancies1R21CA256605-01 · under PAR-19-149 | RAIKAR, SUNIL SUDHIRSULCHEK, TODD | EMORY UNIVERSITY, GA | $223,162 | CII |
| 2021 | Engineered Enteric Nervous System-Peri Neural Invasion platform to improve predictive preclinical screens in early-stage colorectal adenocarcinomas1R21CA263768-01 · under PAR-19-149 | RAGHAVAN, SHREYA | TEXAS ENGINEERING EXPERIMENT STATION, TX | $219,700 | CMT |
| 2021 | Tumor-permeable nanoparticles for enhanced pancreatic cancer immunochemotherapy1R21CA249649-01A1 · under PAR-19-149 | SUN, JINGJING | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $218,699 | ZRG1 |
| 2021 | Two-Dimensional Multi-Stage Isotachophoretic Technology for Multiplex Analysis of Cancer Exosomes and Proteins Marker Panel1R21CA248734-01A1 · under PAR-19-149 | DONG, WEN-JI | WASHINGTON STATE UNIVERSITY, WA | $207,968 | CBSS |
| 2021 | Self-assembled iron(III) hosts for MRI-guided delivery of chemotherapeutics1R21CA256602-01A1 · under PAR-19-149 | MORROW, JANET RUTH | STATE UNIVERSITY OF NEW YORK AT BUFFALO, NY | $200,631 | IPCA |
| 2021 | Live-cell intracellular immunofluorescence1R21CA263698-01 · under PAR-19-149 | GAO, XIAOHU | UNIVERSITY OF WASHINGTON, WA | $181,741 | CMT |
| 2021 | ROS-induced SPIO Targeted Platform for Transarterial Liver Cancer Therapy1R21CA249828-01A1 · under PAR-19-149 | FARSAD, KHASHAYAR | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $179,988 | DMP |
| 2021 | Domain-Knowledge Informed Deep Learning for Early Detection of Pancreatic Cancer1R21CA265400-01 · under PAR-19-149 | HUR, CHINTATONETTI, NICHOLAS P | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $176,874 | ZRG1 |
| 2021 | Site-Specific Antibody for Protein Poly-ADP-Ribosylation1R21CA261018-01 · under PAR-19-149 | YU, YONGHAO | UT SOUTHWESTERN MEDICAL CENTER, TX | $173,859 | RTB |
| 2021 | Bcl-2 as a target in cancer1R21CA249627-01A1 · under PAR-19-149 | KOLLURI, SIVA KUMAR | OREGON STATE UNIVERSITY, OR | $173,559 | MCT2 |
| 2021 | Coded-aperture Compton scatter imaging for real-time tumor motion tracking during ablative radiotherapy1R21CA249647-01A1 · under PAR-19-149 | JONES, BERNARD L | UNIVERSITY OF COLORADO DENVER, CO | $172,460 | IGIS |
| 2021 | Mapping protein dynamics and their origin at biomaterial surfaces in vivo1R21AR079154-01 · under PAR-19-149 | BRYANT, STEPHANIE JCALVE, SARAH | UNIVERSITY OF COLORADO, CO | $167,473 | MTE |
| 2021 | Controllable 2- and 3D Assembly of Mechanically Robust Skin Tissue Via Long Term Expression of DNA on Cell Membranes1R21AR078506-01 · under PAR-19-149 | CHA, JENNIFER NGOODWIN, ANDREW P | UNIVERSITY OF COLORADO, CO | $157,677 | BMBI |
| 2020 | Secretable theranostic payloads to augment the efficacy of adoptive CAR-T cell therapies1R21CA250478-01A1 · under PAR-19-149 | PONOMAREV, VLADIMIR | SLOAN-KETTERING INST CAN RESEARCH, NY | $455,112 | ZRG1 |
| 2020 | In situ cancer cell specific synthesis of gold nanoclusters for radiosensitization of pancreatic cancer1R21CA252156-01 · under PAR-19-149 | KRISHNAN, SUNILSOKOLOV, KONSTANTIN V | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $425,381 | NANO |
| 2020 | Image guidance for trans-oral robotic surgery1R21CA246158-01A1 · under PAR-19-149 | HALTER, RYAN JOSEPH | DARTMOUTH COLLEGE, NH | $407,096 | IGIS |
| 2020 | Engineering ex vivo models of lung cancer and chemoprevention1R21CA252172-01 · under PAR-19-149 | MAGIN, CHELSEA MTENNIS, MEREDITH A | UNIVERSITY OF COLORADO DENVER, CO | $399,830 | CMT |
| 2020 | Fructose Metabolism as a Biomarker for Monitoring Hepatocellular Carcinoma1R21CA245492-01A1 · under PAR-19-149 | TEE, SUI SENG | UNIVERSITY OF MARYLAND BALTIMORE, MD | $397,258 | CBSS |
| 2020 | Advanced Microscopy Tools for Ultra-High Throughput Spatially Resolved Single-Cell Transcriptomics1R21CA249728-01 · under PAR-19-149 | MOFFITT, JEFFREY | BOSTON CHILDREN'S HOSPITAL, MA | $244,075 | ISD |
| 2020 | PET Imaging Biomarkers to Predict Cardiac Remodeling and Functional Decline in Cardiotoxicity Arising from Chemotherapy1R21CA246409-01 · under PAR-19-149 | BABICH, JOHN WKELLY, JAMES | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $237,724 | IPCA |
| 2020 | Somatostatin receptor 2 (SSTR2) antibody-drug conjugate for pancreatic neuroendocrine tumor (PanNET) therapy1R21CA226491-01A1 · under PAR-19-149 | JASKULA-SZTUL, RENATALIU, XIAOGUANG MARGARETVELU, SADANANDAN E. | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $199,497 | DT |
| 2020 | Development of synergistic oxygenating antibacterial hydrogel dressings for reducing infection in diabetic wounds1R21AR074743-01A1 · under PAR-19-149 | LEIPZIG, NIC D | UNIVERSITY OF AKRON, OH | $198,150 | ACTS |
| 2020 | Discovering proteins that explain single-cell heterogeneity in fibrillar migration1R21CA246150-01A1 · under PAR-19-149 | ASTHAGIRI, ANAND R | NORTHEASTERN UNIVERSITY, MA | $183,494 | EBIT |
| 2020 | Parametric optimization of ultrasound-mediated immuno-modulation for pancreatic cancer therapy1R21CA246550-01A1 · under PAR-19-149 | DAYTON, PAUL APYLAYEVA-GUPTA, YULIYA | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $179,226 | IGIS |
| 2020 | Ectopic centromere assembly in humans1R21CA238758-01A1 · under PAR-19-149 | SULLIVAN, BETH A | DUKE UNIVERSITY, NC | $178,473 | GCAT |
| 2020 | Prostaglandin E2 receptor 2 (EP2) as a Target for Prevention of the Foreign Body Response1R21AR077419-01 · under PAR-19-149 | BRYANT, STEPHANIE J | UNIVERSITY OF COLORADO, CO | $175,516 | ZRG1 |
| 2020 | Development of single cell magnetophoresis to analyze and isolate glioma cancer stem cells1R21CA250118-01 · under PAR-19-149 | CHALMERS, JEFFREY JOHNVENERE, MONICA | OHIO STATE UNIVERSITY, OH | $174,204 | CMT |
| 2020 | Image-guided, ultrasound-enhanced long-term intracranial drug delivery1R21CA246414-01 · under PAR-19-149 | BRUDNO, YEVGENYDAYTON, PAUL A | NORTH CAROLINA STATE UNIVERSITY RALEIGH, NC | $167,930 | IGIS |
| 2019 | Identification of prostate cancer aggressiveness using hyperpolarized polyamine metabolic rates1R21CA243255-01 · under PA-18-286 | CHENG, LEO L | MASSACHUSETTS GENERAL HOSPITAL, MA | $251,698 | ZRG1 |
| 2019 | Noninvasive bioluminescent imaging of neuronal activity in freely behaving animals1R21DA048252-01 · under PA-18-286 | LIN, MICHAEL Z. | STANFORD UNIVERSITY, CA | $237,223 | MNG |
| 2019 | Ultra-high-dose-rate proton therapy for malignant glioma1R21CA226562-01A1 · under PA-18-286 | ELEY, JOHN G. | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $235,684 | RTB |
| 2019 | Sigma-1 Receptors: A Novel Clinical Target in Fragile X Syndrome1R21HD095319-01A1 · under PA-18-286 | CHIN, FREDERICK T | STANFORD UNIVERSITY, CA | $234,750 | CMIP |
| 2019 | Perinatal Brain Injury: Identifying Cortical Excitability and Circuitry through Multi-Modal Assessment1R21HD097575-01A1 · under PA-18-286 | GILLICK, BERNADETTE THERESE | UNIVERSITY OF MINNESOTA, MN | $223,038 | MFSR |
| 2019 | Bio-Physical Modeling of Immuno-Radiotherapy Combinations based on Patient Data1R21CA241918-01 · under PA-18-286 | GRASSBERGER, CLEMENS | MASSACHUSETTS GENERAL HOSPITAL, MA | $216,282 | RTB |
| 2019 | MM-WAVE IMAGING FOR USE IN RADIATION ONCOLOGY1R21CA227586-01A1 · under PA-18-286 | REILLY, MICHAEL | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $215,693 | RTB |
| 2019 | Bionic Breast Project: Towards Restoring Breast Sensory Function in Women with Mastectomy1R21CA226726-01A1 · under PA-18-286 | BENSMAIA, SLIMANLINDAU, STACY TESSLER | UNIVERSITY OF CHICAGO, IL | $208,821 | BMIO |
| 2019 | Elucidating chromatin organization with molecular rulers1R21CA235421-01 · under PA-18-286 | YIN, PENG | HARVARD UNIVERSITY, MA | $204,994 | GCAT |
| 2019 | Visualizing radiation-induced tumor immune responses1R21CA228542-01A1 · under PA-18-286 | SCHAUE, DORTHEWU, ANNA M | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | $199,166 | CII |
| 2019 | Soluble and mechanical factors directing mesothelial cell migration in clearance during ovarian cancer metastasis1R21CA227922-01A1 · under PA-18-286 | KREEGER, PAMELA KNOTBOHM, JACOB K | UNIVERSITY OF WISCONSIN-MADISON, WI | $196,033 | TPM |
| 2019 | Dissecting the functions of diverse macrophage populations in the metastatic niche1R21CA235385-01 · under PA-18-286 | SCHWERTFEGER, KATHRYN LWOOD, DAVID KEVIN | UNIVERSITY OF MINNESOTA, MN | $194,893 | TME |
| 2019 | Determination of the Recruitment of Indirect Motor Pathways in Chronic Hemiparetic Stroke1R21HD099710-01 · under PA-18-286 | DEWALD, JULIUS PYANG, YUAN | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $188,514 | MFSR |
| 2019 | Engineering CARs against cancer-specific glycoproteins1R21CA238628-01A1 · under PA-18-286 | KRANZ, DAVID M. | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL | $185,962 | CII |
| 2019 | 3D Imaging of Tumor Mechanobiology Using Nanobomb Optical Coherence Elastography1R21CA231561-01A1 · under PA-16-040 | SOKOLOV, KONSTANTIN V | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $184,005 | NANO |
| 2019 | Automatic analysis of 3D skin images for chronic graft-versus-host disease (cGVHD) severity assessment1R21AR074589-01 · under PA-18-286 | DAWANT, BENOIT M. | VANDERBILT UNIVERSITY, TN | $179,706 | MEDI |
| 2019 | Concurrent High-Speed fMRI and Diffusion Tensor MRSI1R21CA241714-01 · under PA-18-286 | POSSE, STEFAN | UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR, NM | $176,501 | EITA |
| 2019 | Energy-Based Scatter Estimation Algorithm for Accurate Quantitative PET Imaging1R21CA239177-01A1 · under PA-18-286 | SURTI, SULEMAN | UNIVERSITY OF PENNSYLVANIA, PA | $176,175 | BMIT |
| 2019 | Suppression of disease causingnonsense mutations by targeted mRNA pseudouridylation1R21CA241111-01 · under PA-18-286 | YU, YI-TAO | UNIVERSITY OF ROCHESTER, NY | $167,475 | MGA |
| 2019 | Aptamer-based radiopharmaceuticals for the targeted alpha particle therapy of prostate cancer1R21CA227709-01A1 · under PA-18-286 | GMEINER, WILLIAM H.WADAS, THADDEUS J. | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $165,517 | RTB |
| 2019 | A Tissue Engineering Approach to Analyzing Host-Microbe Interactions in Cancer1R21CA238630-01A1 · under PA-18-286 | SLADE, DANIEL JVERBRIDGE, SCOTT S | VIRGINIA POLYTECHNIC INST AND ST UNIV, VA | $162,377 | CMT |
| 2019 | Preclinical Validation of Dual-Modal Nanotherapy for Chronic Myeloid Neoplasms and Beyond1R21CA228099-01A1 · under PA-18-286 | KWON, YOUNG JIK | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $158,960 | MCH |
| 2018 | Bioengineering of vein grafts to resist intimal hyperplasia1R21EB024308-01A1 · under PA-16-040 | FERRAN, CHRISTIANE | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $262,500 | BTSS |
| 2018 | High-performance Positron Emission Tomography for brain imaging1R21EB023391-01A1 · under PA-16-040 | SABET, HAMID | MASSACHUSETTS GENERAL HOSPITAL, MA | $252,750 | BMIT |
| 2018 | Immune-Cancer Cell Interactions in a 3D Bioprinted Tumor Microenvironment1R21CA224422-01A1 · under PA-16-040 | UNUTMAZ, DERYA | JACKSON LABORATORY, ME | $243,860 | BMBI |
| 2018 | Physeal cartilage tissue engineering using mesenchymal stem cells directed towards chondrogenesis1R21HD092109-01A1 · under PA-16-040 | BRYANT, STEPHANIE JPAYNE, KARIN A | UNIVERSITY OF COLORADO DENVER, CO | $238,144 | SBSR |
| 2018 | Measuring CSF shunt flow with MRI using flow enhancement of signal intensity (Shunt-FENSI)1R21HD095314-01 · under PA-16-040 | SUTTON, BRADLEY P | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL | $237,463 | MEDI |
| 2018 | Physical detection of HLA-C binding peptides to identify and predict immunogenic personal neoepitopes for improving cancer vaccines1R21CA216772-01A1 · under PA-16-040 | KESKIN, DERIN B | DANA-FARBER CANCER INST, MA | $232,224 | CII |
| 2018 | 3D Bioprinting for Esophageal Reconstruction1R21EB022830-01A1 · under PA-16-040 | PANOSKALTSIS-MORTARI, ANGELA | UNIVERSITY OF MINNESOTA, MN | $230,250 | BTSS |
| 2018 | Intraoperative Measurement of Ligament Tension to Guide Knee Arthroplasty1R21EB024957-01A1 · under PA-16-040 | THELEN, DARRYL G | UNIVERSITY OF WISCONSIN-MADISON, WI | $223,140 | BTSS |
| 2018 | Reducing recall rates of screening mammography with deep convolutional neural network1R21CA225175-01A1 · under PA-16-040 | KIM, SUNGHEON GENEMOY, LINDA | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $218,865 | BMIT |
| 2018 | Blocking ligand-dependent BMP signaling as an anti-melanoma strategy1R21CA228120-01 · under PA-16-040 | CEOL, CRAIG JOSEPH | UNIV OF MASSACHUSETTS MED SCH WORCESTER, MA | $218,588 | CII |
| 2018 | Rapid High-Resolution 1H-MRSI for Metabolic Imaging of the Brain1R21EB023413-01A1 · under PA-16-040 | LIANG, ZHI-PEI | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL | $217,844 | BMIT |
| 2018 | 3D biomimetic image-based stromal models of pancreatic cancer for drug screening1R21CA224280-01A1 · under PA-16-040 | CAMPAGNOLA, PAUL JSKALA, MELISSA CAROLINE | UNIVERSITY OF WISCONSIN-MADISON, WI | $213,829 | CMT |
| 2018 | Extracellular matrix regulation of lung adenocarcinoma signaling and drug responsiveness1R21CA216066-01A1 · under PA-16-040 | UNDERHILL, GREGORY H | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL | $211,797 | TME |
| 2018 | Elucidating skeletal stem cell function using engineered 3D multicellular structures1R21AR072778-01 · under PA-16-040 | HSIAO, EDWARD C | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $210,925 | SBSR |
| 2018 | Taste Receptor Family 2 Member 9 as a novel target for imaging Cancer Associated Fibroblasts in pancreatic cancer1R21CA231196-01 · under PA-16-040 | KELLY, KIMBERLY A. | UNIVERSITY OF VIRGINIA, VA | $210,703 | CMIP |
| 2018 | High Sensitivity Detection of Mutant cf-ctDNA with DNA-Guided Argonaut Enzymes1R21CA227056-01 · under PA-16-040 | BAU, HAIM H | UNIVERSITY OF PENNSYLVANIA, PA | $210,105 | GCAT |
| 2018 | Immunoswitch: A novel nanoparticle-based approach to immunotherapy1R21EB023411-01A1 · under PA-16-040 | SCHNECK, JONATHAN P | JOHNS HOPKINS UNIVERSITY, MD | $204,688 | TTT |
| 2018 | Targeting tissue factor as a novel oncotarget for immunotherapy of triple negative breast cancer1R21CA216697-01A1 · under PA-16-040 | HU, ZHIWEI | OHIO STATE UNIVERSITY, OH | $203,580 | CII |
| 2018 | Ultrasound elestography for non-invasive assessment of tendon healing1R21AR073961-01 · under PA-16-040 | LOISELLE, ALAYNARICHARDS, MICHAEL SCOTT | UNIVERSITY OF ROCHESTER, NY | $203,280 | SBSR |
| 2018 | Development of intensity modulated radiation therapy for small animal research1R21CA228160-01 · under PA-16-040 | SHENG, KE | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $202,819 | RTB |
| 2018 | RADIOMICS-BASED PROGNOSTIC MODEL OF CERVICAL CANCER HABITATS1R21CA223799-01 · under PA-16-040 | GRIGSBY, PERRY WAYNELI, HUA | WASHINGTON UNIVERSITY, MO | $202,601 | RTB |
| 2018 | Microfluidic Photoreactor for Treatment of Hyperbilirubinemia1R21HD096301-01 · under PA-16-040 | BAIO, JOE EHIGGINS, ADAM ZSCHILKE, KATE F | OREGON STATE UNIVERSITY, OR | $201,837 | ISD |
| 2018 | Antibody-Molecular Container Conjugates for Targeted Delivery1R21CA226830-01 · under PA-16-040 | BRIKEN, VOLKERISAACS, LYLE D | UNIV OF MARYLAND, COLLEGE PARK, MD | $198,276 | SBCA |
| 2018 | Nanotechnology for Non-perturbative, Longitudinal Sampling from hiPSC Cardiomyocytes1R21EB025332-01 · under PA-16-040 | MELOSH, NICHOLAS A | STANFORD UNIVERSITY, CA | $196,250 | ISD |
| 2018 | 3D Printing of Anatomically Realistic Phantoms for Optimization of Imaging Algorithms1R21EB025549-01A1 · under PA-16-040 | LO, JOSEPH YWILEY, BENJAMIN J. | DUKE UNIVERSITY, NC | $189,424 | BMIT |
| 2018 | Self-administration of Near-Infrared Fluorescent Molecular Imaging Probes for Non-Invasive Early Detection and Treatment Monitoring of Rheumatoid Arthritis1R21AR072314-01A1 · under PA-16-040 | THURBER, GREG | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $187,785 | ACTS |
| 2018 | Amniotic Membrane Derived Matrix for Large Bone Defect Repair1R21DE026582-01A1 · under PA-16-040 | HARLEY, BRENDAN A.WHEELER, MATTHEW B | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL | $187,318 | ODCS |
| 2018 | Interrogating tension-adhesion coupling via high-speed deformation-relaxation1R21CA220202-01A1 · under PA-16-040 | LIN, HAO | RUTGERS, THE STATE UNIV OF N.J., NJ | $184,659 | MABS |
| 2018 | Mutagenesis and migration in glioblastoma cells1R21CA220111-01A1 · under PA-16-040 | AHN, EUN HYUN | UNIVERSITY OF WASHINGTON, WA | $179,240 | RTB |
| 2018 | Highly Accelerated Chemical Exchange Saturation Transfer MRI Using Compressed Sensing1R21CA227783-01A1 · under PA-16-040 | HEO, HYE YOUNG | JOHNS HOPKINS UNIVERSITY, MD | $178,056 | BMIT |
| 2018 | Enabling NIR-PIT therapy to treat deep-tissue cancer1R21CA223969-01A1 · under PA-16-040 | SADDOW, STEPHEN EDWARD | UNIVERSITY OF SOUTH FLORIDA, FL | $177,876 | MEDI |
| 2018 | Microfluidic Engineering of Artificial-Antigen Presenting Cells for the Biomanufacturing of Tumor-Specific T-Cells1R21EB026900-01 · under PA-16-040 | LEE, ABRAHAM P | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $176,380 | ZRG1 |
| 2018 | In situ Investigation of dynamic protein-protein interactions in live cells via Magnetic Co-concentration (MCoC)1R21CA224364-01 · under PA-16-040 | JUN, YOUNG-WOOK | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $173,728 | ISD |
| 2018 | Targeting the CAR Membrane Microenvironment to Enhance the Sensitivity of Receptor Triggering1R21CA226962-01 · under PA-16-040 | VEATCH, SARAH L | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $169,378 | BBM |
| 2018 | Synthetic nucleocapsids: a new peptide library platform1R21CA232430-01 · under PA-16-040 | KING, NEILPUN, SUZIE H. | UNIVERSITY OF WASHINGTON, WA | $169,106 | NANO |
| 2018 | Single cell functional dissection of tumor microenviornment-driven drug resistance1R21CA220082-01A1 · under PA-16-040 | WOOD, KRIS C. | DUKE UNIVERSITY, NC | $164,963 | BMCT |
| 2018 | A Synthetic Bone Marrow to Understand Breast Cancer Dormancy1R21CA223783-01A1 · under PA-16-040 | PEYTON, SHELLY R. | UNIVERSITY OF MASSACHUSETTS AMHERST, MA | $161,059 | ICI |
| 2017 | Characterization of Thyroid Nodules by Quantitative Ultrasound1R21CA212744-01 · under PA-16-040 | LEE, STEPHANIE L. | BOSTON MEDICAL CENTER, MA | $274,504 | BMIT |
| 2017 | Syndecan-1 in Mechanosensing of Engineered Microenvironments1R21EB023551-01A1 · under PA-16-040 | BAKER, AARON BLAIR | UNIVERSITY OF TEXAS AT AUSTIN, TX | $251,650 | BMBI |
| 2017 | Development of Hybrid Tracheas for Long-Segment Tracheal Reconstruction1R21EB025378-01 · under PA-16-040 | LIN, CHIA-YING JAMES | UNIVERSITY OF CINCINNATI, OH | $244,703 | BMBI |
| 2017 | A Low-Cost Tethered Capsule Endoscope for Esophageal Cancer Screening1R21EB023431-01 · under PA-16-040 | RICHARDS-KORTUM, REBECCA R. | RICE UNIVERSITY, TX | $243,585 | BMIT |
| 2017 | High-Frequency Resting State Connectivity fMRI1R21EB022803-01A1 · under PA-16-040 | POSSE, STEFAN | UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR, NM | $241,331 | ZRG1 |
| 2017 | Morphogenetic Self-Assembly of Human Heart Organoids1R21EB023573-01A1 · under PA-16-040 | COSTA, KEVIN DSACHS, DAVID | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $240,350 | BMBI |
| 2017 | Fast Methods for Mapping Focused Ultrasound Pressure Fields1R21EB024199-01A1 · under PA-16-040 | GRISSOM, WILLIAM A | VANDERBILT UNIVERSITY, TN | $235,694 | BMIT |
| 2017 | Glycocalyx Mimetic Polysaccharides as Therapeutics for Atherosclerosis1R21EB024147-01A1 · under PA-16-040 | BAKER, AARON BLAIR | UNIVERSITY OF TEXAS AT AUSTIN, TX | $234,750 | AICS |
| 2017 | A High Throughput, Human, In Vitro Model of Neuronal Stretch Injury1R21NS098129-01A1 · under PA-16-040 | FINAN, JOHN D | ENDEAVOR HEALTH CLINICAL OPERATIONS, IL | $234,000 | ZRG1 |
| 2017 | Plasma clearance of water soluble and albumin bound toxins using graphene oxide nanoengineered laminates1R21EB023527-01A1 · under PA-16-040 | GABORSKI, THOMAS RMOGHADDAM, SAEED | UNIVERSITY OF FLORIDA, FL | $232,294 | NANO |
| 2017 | Radiolabeled FASN Inhibitors for PET Imaging1R21CA213157-01 · under PA-16-040 | BABICH, JOHN W | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $229,013 | CMIP |
| 2017 | Establishing Mechanisms of Human Proximal Tubule Regeneration in an Engineered Organ on Chip Platform1R21EB025534-01 · under PA-16-040 | MCCAIN, MEGAN LAURAMCMAHON, ANDREW P. | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $228,380 | PBKD |
| 2017 | Imaging the efficacy of TRAIL-enhanced cancer immunotherapy1R21CA213139-01A1 · under PA-16-040 | ADUSUMILLI, PRASAD S.PONOMAREV, VLADIMIR | SLOAN-KETTERING INST CAN RESEARCH, NY | $225,504 | MEDI |
| 2017 | Robotic platform for high-density in vivo intracellular recording from mammalian circuits1R21NS103098-01 · under PA-16-040 | HARNETT, MARK THOMASKODANDARAMAIAH, SUHASA B | UNIVERSITY OF MINNESOTA, MN | $223,890 | BNVT |
| 2017 | High speed ultrasonic communications for implanted medical devices1R21EB025327-01 · under PA-16-040 | OELZE, MICHAEL L. | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL | $220,858 | BMIT |
| 2017 | Novel Reconstruction Paradigm for Multiphasic CT Imaging of Kidney Cancer1R21CA211035-01A1 · under PA-16-040 | NOO, FREDERICXU, JINGYAN | UNIVERSITY OF UTAH, UT | $215,483 | BMIT |
| 2017 | Multifunctional fibers for high-throughput microfluidics1R21EB022729-01A1 · under PA-16-040 | FINK, YOELVOLDMAN, JOEL | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | $206,954 | ISD |
| 2017 | Dissecting protein activities by reversible photo-inactivation1R21CA224194-01 · under PA-16-040 | WITTMANN, TORSTEN | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $206,843 | ZRG1 |
| 2017 | A new class of CSF-1R radioligands for monitoring glioblastoma progression and therapy1R21CA205564-01A1 · under PA-16-040 | CHIN, FREDERICK T | STANFORD UNIVERSITY, CA | $205,187 | CMIP |
| 2017 | Epigenetic modulation of SEC24D and circulating miR-605 in renal cell carcinoma1R21CA213977-01A1 · under PA-16-040 | PILI, ROBERTO | INDIANA UNIVERSITY INDIANAPOLIS, IN | $203,580 | CONC |
| 2017 | Detecting Mammographically-Occult Cancer in Women with Dense Breasts1R21CA216495-01 · under PA-16-040 | NISHIKAWA, ROBERT M | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $202,275 | BMIT |
| 2017 | Mechano-Sensing CAR-T Cells for Solid Tumor Metastases1R21CA219225-01 · under PA-16-040 | ZHAO, WEIAN | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $201,585 | BMBI |
| 2017 | Using Second Harmonic Generation to Predict Metastatic Outcome in Colon Adenocarcinoma1R21CA208921-01A1 · under PA-16-040 | BROWN, EDWARD BERNARD | UNIVERSITY OF ROCHESTER, NY | $200,807 | BMIT |
| 2017 | Endothelial DNA Methylation, Arteriogenic Capacity, and Shear Stress "Set-Point."1R21EB024323-01A1 · under PA-16-040 | PRICE, RICHARD J. | UNIVERSITY OF VIRGINIA, VA | $200,313 | VCMB |
| 2017 | In Vivo Arthrokinematics of Total Ankle Replacement and Ankle Arthrodesis1R21AR069773-01A1 · under PA-16-040 | ANDERSON, ANDREW EDWARD | UNIVERSITY OF UTAH, UT | $199,815 | MRS |
| 2017 | Noninvasive Pressure Estimation in Breast Cancer using Ultrasound1R21CA212851-01 · under PA-16-040 | HOYT, KENNETH | UNIVERSITY OF TEXAS DALLAS, TX | $199,665 | BMIT |
| 2017 | Noninvasive Detection of Prostate Cancer with a Label-Free Imaging System1R21CA198389-01A1 · under PA-16-040 | YE, JING YONG | UNIVERSITY OF TEXAS SAN ANTONIO, TX | $198,406 | ZRG1 |
| 2017 | Cancer Targeting through Drug Conjugates1R21CA198684-01A1 · under PA-16-040 | CHENG, JIANJUN | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL | $197,838 | ZRG1 |
| 2017 | Evaluation of machine learning to mobilize detection and therapy of developmental delay in children1R21HD091500-01 · under PA-16-040 | WALL, DENNIS PAUL | STANFORD UNIVERSITY, CA | $196,250 | CPDD |
| 2017 | Application of Single Cell Technologies to Resolve SI-NET Cell of Origin and Cytome Signature1R21CA215900-01 · under PA-16-040 | MAGNESS, SCOTT T | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $196,210 | BMBI |
| 2017 | Kinetic modeling of multiplexed SERS nanoparticles for quantitative molecular phenotyping (QMP) of breast cancer1R21CA215561-01 · under PA-16-040 | LIU, JONATHAN T.C. | UNIVERSITY OF WASHINGTON, WA | $195,523 | BMIT |
| 2017 | Enabling Diffusion-Weighted MRI Near Metallic Implants1R21EB023415-01A1 · under PA-16-040 | KOCH, KEVIN M | MEDICAL COLLEGE OF WISCONSIN, WI | $190,799 | BMIT |
| 2017 | Osteoinductive Microgel-Based Scaffolds for hMSC Delivery1R21AR071625-01 · under PA-16-040 | ALGE, DANIEL | TEXAS ENGINEERING EXPERIMENT STATION, TX | $190,196 | MTE |
| 2017 | DECONVOLUTION OF CLONAL HETEROGENEITY FROM BULK AND SINGLE-CELL VARIATION DATA1R21CA216452-01 · under PA-16-040 | SCHWARTZ, RUSSELL S | CARNEGIE-MELLON UNIVERSITY, PA | $187,064 | MABS |
| 2017 | Engineering Antibody Drug Conjugates To Target P53-Defective Triple Negative Breast Cancer1R21CA213535-01A1 · under PA-16-040 | LU, XIONGBINWANG, JIN | BAYLOR COLLEGE OF MEDICINE, TX | $185,933 | CII |
| 2017 | Metabolic Sodium MRI to Assess Early Response of Breast Cancer to Neoadjuvant Chemotherapy1R21CA213169-01A1 · under PA-16-040 | BROWN, RYANMADELIN, GUILLAUME | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $184,331 | BMIT |
| 2017 | Scatter imaging for stereotactic ablative radiation therapy of lung cancer1R21CA213407-01A1 · under PA-16-040 | CHU, JAMES C.H. | RUSH UNIVERSITY MEDICAL CENTER, IL | $178,829 | BMIT |
| 2017 | CEST MRI assessment of tumor vascular permeability using non-labeled dextrans1R21CA215860-01 · under PA-16-040 | LIU, GUANSHU | HUGO W. MOSER RES INST KENNEDY KRIEGER, MD | $175,782 | GDD |
| 2017 | Imaging CAncer Screening Patch (CASP) for early diagnostics of cervical cancers1R21CA209063-01A1 · under PA-16-040 | TKACZYK, TOMASZ S | RICE UNIVERSITY, TX | $174,374 | BMIT |
| 2017 | Reprogramming Tumor-Associated Macrophages in PDAC with MicroRNA Nano-Vectors1R21CA213114-01A1 · under PA-16-040 | AMIJI, MANSOOR M.MACKENZIE, GERARDO GUILLERMO | NORTHEASTERN UNIVERSITY, MA | $170,738 | DMP |
| 2017 | Non-Destructive Spectroscopic Assessment of Bone Water at Microscopic Resolution1R21AR071704-01 · under PA-16-040 | PLESHKO, NANCY | TEMPLE UNIV OF THE COMMONWEALTH, PA | $170,387 | MTE |
| 2017 | Cancer Cell Mechanical Profiling Analysis1R21CA208196-01A1 · under PA-16-040 | RAO, JIANYU | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $168,744 | CBSS |
| 2017 | Nanoparticle-based synthetic transcription factor to induce stem cell myogenesis1R21AR071101-01A1 · under PA-16-040 | LEE, KIBUM | RUTGERS, THE STATE UNIV OF N.J., NJ | $168,194 | MTE |
| 2017 | Hyperpolarized 13C imaging of mitochondrial metabolism for improved characterization of prostate cancer1R21CA213020-01 · under PA-16-040 | MAYER, DIRKSIDDIQUI, MOHUMMAD MINHAJ | UNIVERSITY OF MARYLAND BALTIMORE, MD | $167,702 | CMIP |
| 2017 | A Hydrogel Model for Interstitial Fluid Flow1R21AR069791-01A1 · under PA-16-040 | BRYANT, STEPHANIE JFERGUSON, VIRGINIA LEA | UNIVERSITY OF COLORADO, CO | $155,878 | SBSR |
| 2016 | Advanced Ventricular Assist Device with Pulse Augmentation and Automatic Regurgitant Flow Shutoff1R21HL133871-01 · under PA-12-284 | FUKAMACHI, KIYOTAKA | CLEVELAND CLINIC LERNER COM-CWRU, OH | $315,578 | BTSS |
| 2016 | Microdroplet Transporter Protein Assays1R21EB022206-01 · under PA-12-284 | FARIS, GREGORY W | SRI INTERNATIONAL, CA | $306,112 | ZRG1 |
| 2016 | Determining the Biomechanical and Biological Response of Stretched Skin1R21EB021590-01A1 · under PA-12-284 | GOSAIN, ARUN K | LURIE CHILDREN'S HOSPITAL OF CHICAGO, IL | $289,809 | ZRG1 |
| 2016 | Development of Small Molecule Inhibitors of IL-18 to Prevent Intimal Hyperplasia1R21HL133821-01 · under PA-12-284 | PRADHAN-NABZDYK, LEENASUN, LIJUN | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $259,500 | BTSS |
| 2016 | Computerized Visualization and Prediction of Coronary Artery Ischemia1R21HL132277-01 · under PA-12-284 | KUCEYESKI, AMY FRANCESMIN, JAMES K | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $254,250 | BMIT |
| 2016 | MIF20-loaded nanoparticles for TBI treatment1R21NS095147-01 · under PA-12-284 | DE LANEROLLE, NIHAL CZHOU, JIANGBING | YALE UNIVERSITY, CT | $250,750 | BNVT |
| 2016 | "Optogenetic control of amyloid beta protective gene expression in the C. elegans gut microbiota"1R21NS099870-01 · under PA-16-040 | TABOR, JEFFREY JAY | RICE UNIVERSITY, TX | $250,375 | EBIT |
Showing the 200 most recent of 388 awards.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.